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Abstract Silica, silica/polydimethylsiloxane and silica/polydimethylsiloxane/
calcium xerogels were examined as polymeric carriers for the controlled release of
drug—Metronidazole. Characterization assays comprised analysis of the matrix by
Fourier transform infrared spectroscopy (FTIR), determining the specific surface
area of solids (BET) and scanning electron microscope (SEM) techniques and
further monitoring in the ultraviolet and visible light regions (UV–Vis) of the in
vitro release of the drug over time. Using tetramethoxysilane (TMOS) as a precursor
of silica matrix and polydimethylsiloxane (PDMS) and calcium ions as additives,
xerogels with different morphology and physical properties were obtained. The
applied modifications diminished the porosity and hydrophilicity of the silica matrix
as well as reduced the release of drug. Based on the presented results of this study, it
may be stated that applied xerogel matrices, pure silica (SiO2) and modified silica
(SiO2–CaO, SiO2–PDMS and SiO2–CaO–PDMS), could be promising candidates
for the formulation in local delivery systems.
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Introduction
The use of the sol–gel-processed silica materials as biocatalysts, biosensors,
immunodiagnostics or drug delivery systems, in both medicine and the pharma-
ceutical industry, is well reported in the literature [1–10].
The sol–gel procedure is highly efficient due to the low temperature of the
chemical process, high homogeneity and product purity, which enables the insertion
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of numerous biologically active substances into the preparation. Entrapped
molecules retain their conformation, physical characteristics and many of their
chemical and biological properties within the sol–gel materials. Owing to the
porosity of the sol–gel matrix, the molecules are accessible to the external liquid
through the pore network and may be released in a controlled manner from the
matrix to the surrounding liquid. Amorphous biomaterials obtained in this way are
characterized by in vivo biocompatibility and bioactivity since the sol–gel networks
can provide heterogeneous nucleation sites for growth of biological apatite layers
[11–14].
Generally, the sol–gel method involves the hydrolysis of a metal oxide or
alkoxide precursor solution to form a colloidal dispersion—sol, which then
undergoes crosslinking to form a three-dimensional solid network—gel, and further,
after drying—xerogel [15–17].
The sol–gel technique can be used to synthesize pure SiO2, organically modified
silicates by partially replacing TMOS with organic molecules or polymers (PDMS,
PEG and PCL) or inorganically modified with: CaO, P2O5, TiO2, ZrO2.
Structures of these polymer gels can be obtained by chemical or physical
processes. Some gels are cross-linked chemically by covalent bonds (chemical gel),
whereas other gels are cross-linked physically by weak forces, such as hydrogen
bonds, van der Waals forces, or hydrophobic and ionic interactions (physical gel).
Pure silica consists of chemical, covalent bonds between silicon and oxygen atoms.
Organically modified silica (e.g. PDMS) can include both chemical bonding
and physical interaction (van der Waals or hydrophobic forces). Inorganic oxides
(e.g. CaO) often form ionic bonds with silica creating a bond between oxygen atoms
and cations used [18].
These modifications influence the structure and properties of the obtained
matrices, change the hardness, density, porosity and, in consequence, change the
release of biologically active substances (e.g. drugs) [19–21].
Drug molecules are incorporated into the sol–gel matrices by superficial
adsorption (or covalent bonding) or by trapping the molecules in the forming gel
[22].
The latter method is particularly interesting, as not many other matrices offer
such possibilities. Doping some admixture to a colloidal liquid and gelating it result
in the occludation of a molecule in the formed bonds of oxide network. A
consequence of such initiated immobilisation mechanism is the fact that molecules
of variable shapes, sizes and electric charges may be trapped.
In this study, Metronidazole was chosen as the model drug for preparing
controlled delivery systems. Metronidazole is a drug with activity against anaerobic
protozoa, aerobic and microaerophilic bacteria [23, 24]. In medicine, it is used in the
treatment of severe bacteria infections, protozoa genital infections, and as a
prophylactic agent before abdominal surgery. The antibacterial activity against
anaerobic cocci, gram-negative and gram-positive bacilli has led to its use in the
treatment of periodontal disease. Its formula is 2-methyl-5-nitroimidazole-1-ethanol
with an empirical formula of C6H9N3O3 and molecular weight 171.16. The
molecular structure is presented in Fig. 1.
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Oral administration of Metronidazole induces some side effects like hypersensi-
tivity, gastrointestinal intolerance and development of bacterial resistance [25, 26].
Moreover, such a form of application does not give a suitable concentration at the
action site. This efficacy may be improved by the use of local drug delivery systems.
Alternate dosage forms, in which Metronidazole is sustain released from a drug
carrier, could bring about improved therapeutic activity, reduction dosing frequency
and systemic toxicity. The polymers, poly(e-caprolactone), polyethyleneglycol,
hydroxyethyl cellulose, polysiloxanes, natural zeolites and silica and titanium oxides,
calcium phosphate, hydroxyapatite, can be applied as solid dosage forms in
controlling the release of drug and implanted in the vicinity of infection site [23, 25,
27–29]. In this study, as carrier systems for Metronidazole used the SiO2, SiO2–CaO,
SiO2–PDMS and SiO2–CaO–PDMS xerogels. These samples may be used as bone-
substitute materials especially in surgical orthopedics and dentistry by reason of the
bioactive inorganic species—silanol groups (Si–OH) of hydrolyzed TMOS and
calcium ions as well as good flexibility—as result of addition of PDMS.
The drug was incorporated into the xerogels on the stage of the sol. Subsequently,
the research was aimed to determine the kinetics of Metronidazole release from sol–
gel-processed silica xerogels to the dissolution medium (SBF—simulated body
fluid). The aim of the work was to investigate, how inorganic and organic impurities




Tetramethoxysilane (TMOS, C4H12O4Si), hydroxyl-terminated polydimethylsilox-
ane (PDMS, n = 200, d = 0.97), calcium chloride (CaCl2) and drug—Metronida-
zole (2-methyl-5-nitroimidazole-1-ethanol) from Sigma Chemicals Company, were
used without further purification. Ethanol and ammonium hydroxide (from POCh
Co., Poland) were of analytical grade purity.
Simulated body fluid as the dissolution medium for release analysis [30] was
prepared by dissolving reagent grade NaCl (136.8 mM), NaHCO3 (4.2 mM), KCl
(3.0 mM), K2HPO43H2O (1.0 mM), MgCl26H2O (1.5 mM), CaCl22H2O
(2.5 mM), Na2SO4 (0.5 mM) (from POCh Co., Poland, analytical grade purity) in
redistilled water, and the solution was buffered with tris(hydroxymethyl)amino-
methane [TRIZMA] (from Sigma) and hydrochloric acid to pH 7.40.
N
N
CH2 CH2 CH2 OH
CH3O2N
Fig. 1 The molecular structure
of Metronidazole
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Apparatus
A Hewlett Packard 8452A UV–VIS spectrophotometer was used for
spectral measurements over time in the studies of drug release and matrix
degradation.
A magnetic stirrer Heidolph MR Hei-Standard equipped with Contact Ther-
mometer EKT Hei-Con with stainless steel sensor (Germany) was used for
controlling the release conditions.
A Micromeritics ASAP 2405N apparatus was used for measurements of specific
surface area and pore size of the xerogels.
A Jasco FTIR-410 spectrometer was used for the analysis of the chemical
composition of silica xerogels.
A Hitachi Scanning Electron Microscope (SEM) S-2500 (Tokyo, Japan) was used
for examining the microstructure of xerogels.
Preparation of Metronidazole-doped silica xerogels
Silica (SiO2), calcium silicate (SiO2–CaO), SiO2–PDMS and SiO2–CaO–PDMS
hybrid inorganic–organic materials, all mixed with a model drug—Metronidazole,
were prepared by means of sol–gel process [17] under ambient conditions. The mole
ratio of the silica sols were TMOS:PDMS = 2:1, TMOS:CaCl2 = 6:1, TMOS:
H2O = 1:4, pHsol = 9. Gels thus obtained were dried at 50 C for 3 days. Crack-
free monoliths were obtained. The procedures of obtaining different types of
xerogels are given below:
SiO2: a solution of 2.53 mL TMOS precursor in 8 mL MeOH, 1.2 mL water,
0.02 mL of 25% NH3H2O and 0.25 mg of Metronidazole in 2 mL MeOH were
mixed to form homogenous gel. The gelation time for this sol was 15 min.
SiO2–CaO: a solution of 2.2 mL TMOS precursor in 5 mL MeOH and a solution
of 0.28 mg of CaCl2 in 3 mL MeOH were separately stirred for 0.5 h. After that,
the prepared solutions were mixed, and 1 mL water, 0.018 mL of 25% NH3H2O
and 0.25 mg of Metronidazole in 2 mL MeOH were added to form the
homogenous gel. The gelation time for this sol was 10 min.
SiO2–PDMS: a solution of 2.0 mL TMOS precursor in 4 mL MeOH and a
solution of 0.51 mL PDMS in 4 mL MeOH were separately stirred for 0.5 h.
After that, the prepared solutions were mixed, and 1 mL water, 0.018 mL of 25%
NH3H2O and 0.25 mg of Metronidazole in 2 mL MeOH were added to form the
homogenous gel. The gelation time for this sol was 20 min.
SiO2–CaO–PDMS: a solution of 2.0 mL TMOS precursor in 4 mL MeOH, a
solution of 0.51 mL PDMS in 4 mL MeOH and a solution of 0.25 mg of CaCl2 in
1 mL MeOH were separately stirred for 0.5 h. After that, the TMOS and PDMS
prepared solutions were mixed for 0.5 h, and then CaCl2 solution, 1 mL water
and 0.016 mL of 25% NH3H2O and 0.25 mg of Metronidazole in 2 mL MeOH
were added to form the homogenous gel. The gelation time for this sol was
15 min.




The bulk density of the obtained xerogels was calculated from sample weight and
volume.
The porosity of the samples was quantified by surface area and average pore size
measurements.
Specific surface area and pore size of the xerogels were measured using the BET
technique based on nitrogen gas adsorption. Before the measurement, the samples
were crushed and degassed at 200 C. The specific surface area was calculated from
the BET equation. An average pore size was calculated by the BJH method based on
the desorption branch of the isotherm.
The morphology of xerogels was observed using scanning electron microscope.
For SEM, the silica xerogel specimens were mounted on stubs and dried
overnight in a vacuum desiccator. Prior to microscopy, the specimens were sputter
coated with gold (Edwards, Model s150B Sputter Coater). Subsequently, the
specimens were photographed, and the microstructure of the silica xerogels was
examined with a scanning electron microscope.
Molecular (chemical) structure
The chemical composition of silica xerogels was determined with the FTIR
spectrometer. The spectra were measured over a range of 4000–650 cm-1 with an
instrument resolution of 4 cm-1. Each individual spectrum was an average of 36
scans. In this measurement, the pulverized silica xerogels were mixed homoge-
neously with KBr powder, and the background noise was corrected with pure KBr
data.
Stability study
Stability of the matrices was evaluated by the spectrophotometric method based on
the formation of silic-molybdenic blue complex (kmax = 814 nm) to determine the
dissolved Si(OH)4 [31]. The silica xerogel samples were soaked in SBF solution
(0.5 g/50 mL). The intervals were selected based on the silica xerogel matrix
degradation rate. The solutions were analysed daily. The SBF solution was replaced
following each analysis.
The dissolved Si(OH)4 reacted with ammonium molybdate (5%) in pH = 1 to
form silic-molybdenic acid. Then, 0.25% Mohr’s salt (hydrated ammonium
iron(II) sulphate) was added to the silic-molybdenic acid solution to obtain silic-
molybdenic blue complex. Subsequently, the absorbance value at the maximum
absorbance of silic-molybdenic blue complex was measured at wavelength
kmax = 814 nm.
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Drug release monitoring
The drug release process was evaluated via diffusion of Metronidazole from the
pores of the xerogel matrices.
Silica xerogel samples were soaked in 20 mL of SBF as the dissolution medium
and were stirred at 50 rpm at 37 C. The kinetic process was monitored
spectrophotometrically by measuring the absorbance values at the maximum
absorbance of Metronidazole at a wavelength k = 320 nm (in the UV region from
220 to 390 ± 0.1 nm, measured quantity absorbance A ±0.005 a.u.). The
experiments were carried out in duplicate; therefore, only mean values with SD
error bars are reported.
Approximation equation at the confidence interval at level 0.05 (p = 0.05) and
correlation coefficient R = 0.995:
A ¼ 0:0518  C þ 0:0151; ð1Þ
with which the dependence between absorbance (A) and therapeutic agent
concentration (C) was described, made it possible to determine the amount of
released drug in the time function t (min).
Results and discussion
Physical properties
Figure 2 shows the nitrogen adsorption–desorption isotherms for the different
samples of xerogels. According to the Brunauer, Deming, Deming and Teller
(BDDT) classification, the isotherms obtained for SiO2–CaO xerogel at 200 C, is
of type I (Fig. 2a), which is characteristic of a microporous material (pore
radii \ 2 nm). A high volume is absorbed at the lowest relative pressure, which
indicates a large volume of very small pores. The virtual lack of hysteresis in the
desorption branch means that the pores are as large as the openings leading into
them.
The isotherm for the other samples is of type IV (Fig. 2b–d). These isotherms
show low adsorption at low relative pressures, and a sudden increase in adsorption
occurs at high pressure, which is characteristic of a mesoporous solid (pore
radii C 2 nm). The occurrence of hysteresis in the desorption branch is attributed to
the presence of pore cavities larger in diameter than the openings leading into them
[32, 33].
Table 1 summarizes the physical properties of xerogels derived from the
isotherm analysis: BET surface area (SBET), pore volume (Vmp), mean pore radius
(rmp) and also bulk density (q) of the obtained xerogels.
The pure silica xerogel exhibited the high surface area and the largest average
pore size. The SiO2–CaO xerogel showed a negligible increase in surface area but a
decrease in pore volume and pore radius. Modification of material by adding PDMS
decreased both the surface area and the average pore size that indicates decreased
porosities of the samples. This effect is associated with the formation linear, weak
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Fig. 2 Nitrogen adsorption–desorption isotherms of xerogels: a SiO2–CaO, b SiO2, c SiO2–PDMS and
d SiO2–PDMS–CaO
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crosslinking polymers because of the group –CH3 from PDMS which does not
undergo hydrolysis.
The more porous structure of samples correlated well with a decrease of densities
of samples from 1.83 g/cm3 for Ca-modified silica (characteristic for a polymer with
very small pores) to 1.06 g/cm3 for non-modified silica on the largest average pore
size.
Figure 3 shows the scanning electron images of the silica xerogel (Fig. 3a) and
SiO2–PDMS xerogel (Fig. 3b). It is clearly observed that morphology of samples
changes from globular structure for non-modified silica to sample with dense
morphology for that prepared using PDMS as additive. Xerogels without addition of
PDMS have a structure with several smaller agglomerates joining together to form a
larger cluster, while the xerogels with PDMS have a unbranched and less
convoluted structure. Xerogels with addition of CaO, due to the low content of the
calcium oxide, have very similar morphology to their counterparts without calcium
oxide (SiO2 and SiO2–CaO; SiO2–PDMS and SiO2–PDMS–CaO).
Table 1 Some physical properties of the obtained xerogels: pore size (rmp), surface area (SBET), pore
volume (Vmp) and bulk density (q)
Sample rmp (A˚) SBET (m
2 g-1) Vmp (cm
3 g-1) q (g cm-3)
SiO2 46.9456 670 0.83 1.06
SiO2–CaO 20.1914 752 0.253 1.83
SiO2–PDMS 26.8677 273 0.18 1.41
SiO2–PDMS–CaO 27.9589 252 0.21 1.42
Fig. 3 SEM micrographs for a SiO2 and b SiO2–PDMS xerogels. The 10-division scale equals 5.0 lm
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The FTIR spectra of silica xerogels are shown in Fig. 4. The general features of
the spectra of all the silica xerogels are not significantly different. All spectra
present the peaks at:
3500–3750 cm-1—associated with H-bonded SiOH stretching vibrations and
H-bonded water;
1650 cm-1—corresponds to vibrations of water molecule;
1075 cm-1—corresponds to asymmetric stretching vibrations of Si–O–Si bridg-
ing sequences;
795 cm-1—corresponds to symmetric stretching vibrations of Si–O–Si bonds
belonging to ring structures.
Additional peaks at 2800, 1260 and 795 cm-1 are observed when PDMS was
used for the sample preparation. The band at 2800 cm-1 is assigned to the
fundamental stretching vibrations of C–H bonds. The bands at 1260 and 795 cm-1
are due to the bending vibrations of Si–CH3 bonds belonging to PDMS [34, 35].
Significant differences exist for the intensity of the band in the range 4000–
2000 cm-1 for the samples with PDMS and without PDMS. The intensity of the
bond responsible for oscillations in the O–H group is lower for the silica xerogels
that were modified PDMS. This is because of the hydrophobic nature of PDMS that
reduces the O–H group and the water molecules inside of xerogel lattices.
Fig. 4 FTIR spectra of four representative xerogel samples: SiO2, SiO2–CaO, SiO2–PDMS and SiO2–
PDMS–CaO
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Spectral differences for the samples with CaO and without CaO are negligible.
Bands belonging to CaO, occurring in the region of 1700–1460 cm-1, are masked
or occur together with strong bands assigned to the vibration of water molecules.
Study of the stability of the xerogel matrices
Application of variable precursors during silica xerogel synthesis affected the
degradation of the silica xerogel matrix in vitro (Fig. 5).
The tests of the matrix degradation showed, that generally, the degradation
proceeds very slowly (0.52–1.2% per 70 days) in a linear manner.
SiO2 matrix degrades in greatest degree. SiO2 xerogels are hydrophilic polymer
with silanol polar groups on the surface which attract the polar water molecules, so
this matrix takes up large quantities of water and degrades by hydrolysis of the
siloxane bonds through the entire network [36].
Partial substitution of SiO2 with CaO and especially with PDMS results in
decreasing of degree of matrix degradation. This effect could be due to the
increasing hydrophobic character of the matrix (effect of PDMS) and the
diminishing of porosity (effect of CaO). These two factors make it difficult for a
surrounding fluid to penetrate and dissolve the modified silica xerogel matrices. The
study of matrix stability indicates that the low degradation of xerogels also has little
effect on the drug release.
Testing the release of Metronidazole from silica xerogels
Figure 6 displays the plot of the data expressed as the cumulative amount of
Metronidazole released from the xerogel matrices as a function of time. The
findings show that modification of silica xerogel by adding CaO and PDMS resulted




























Fig. 5 Degradation of xerogel matrices
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The formulations displayed negligible different release profiles. The Metronida-
zole was released from SiO2 and SiO2–CaO matrices in a biphasic way characterized
by a faster initial release followed by a slower, steady release.
The silica xerogels modified the PDMS release of drug more monotonously.
In the case of SiO2 matrix, Metronidazole is released rapidly in the first 4 h
(50 ± 2.1%), and then gradually reaches a residual value (98 ± 1.8%) over the next
20 h.
In case of SiO2–CaO matrix, the rate of the drug release took place faster up to
about 2 h (25 ± 2.5%), then the process has become slower. Overall, after 60 h of
the experiment, the maximum amount of Metronidazole released was 71 ± 4%.
Xerogels, SiO2–PDMS and SiO2–PDMS–CaO, showed a final release of 94 ±
3.2% and 90 ± 4.3%, respectively, of encapsulated Metronidazole after 44 h of the
experiment.
Generally, the release of drug from polymeric matrices results from the
combination of diffusion, erosion and swelling of the matrix.
In this study, the erosion of the xerogels is very slowly (0.52–1.2% per 70 days),
while drug release proceed within 1–3 days. Thus, it is reasonable to assume that the
low degradation of xerogels has little effect on the drug release.
Matrix swelling occurs in organic hydrogels with the carbon scaffold. In hybrid
silica xerogels used for the purpose of this study, there are organic groups
constituting end –CH3 group in silica scaffold. Thus, in the case of SiO2–PDMS
xerogels, matrix swelling is not important factor in drug release.
The release of Metronidazole mainly involves the process of diffusion, controlled
from the pores of the xerogels.
In order to confirm the diffusional mechanisms of drug release, release data were
fitted using a semi-empirical Higuchi equation:
Mt=M1 ¼ kt1=2; ð2Þ
where the constant k depends upon the diffusion constant, the porosity and tortuosity



























Fig. 6 Release of Metronidazole from xerogel matrices
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content within the matrix and Mt/M? is the released quantity of the drug and t
represents the exposure time and n = 0.5 is the release exponent indicating the
Fickian diffusion for non-swelling polymers [37, 38].
Figure 7 shows the correlation between Mt/M? and t
1/2 in all Metronidazole-
silica composites, following Eq. 2. Rectilinear dependence between the amount of
the released substance (%) and the square root of the release time (t) suggests that
the Metronidazole is released from the PDMS-modified xerogel samples by
diffusion. In the case of SiO2 and especially SiO2–CaO xerogels with Metronida-
zole, was observed the lack of rectilinearity of the final part of the discussed
dependence. This effect could be due to the complete dissolving of more easily
available drug molecules in the superficial layers of xerogels and slowed release of
model drug from the inner part of matrix.
The drug delivery profiles are dependent on chemical composition and physical
properties of xerogels.
In the case of silica xerogel, the higher release rate of the drug may be attributed
to its increased hydrophilicity. The hydrophilic matrix facilitates SBF solution
penetration inside the silica lattice, dissolves the incorporated molecules of drug and
accelerates the drug molecules diffusion from the matrix to the surrounding fluid.
The observed decrease of Metronidazole release from PDMS-modified xerogels
may be due to steric reasons (both the hydrophobic nature of the CH3-groups from
PDMS inside the pores and small porosity of xerogel lattice), making it difficult for
drug molecules to pass to the water phase.
In the case of CaO-modified xerogels, the lower release rate of the drug may be
attributed to its decreased pore size. During the first 2 h of release, the release
proceeds mainly by dissolution and diffusion of drug in the superficial layers of
xerogel and, additionally, by diffusion of Ca2? ions in contact with water solution.
Therefore, Metronidazole was released quickly at first, in spite of small porosity.
Within the inner part of xerogel, microporous network of matrix effectively
immobilized Metronidazole molecules, making it difficult for the drug to pass to the
surrounding fluid.
Conclusions
The sol–gel method is a powerful approach for producing inorganic and hybrid,
inorganic–organic materials with different morphology and physical properties,
which may be applied in the medicine and the pharmaceutical industry. These
features can be readily modulated by partially replacing TMOS with organic or
inorganic components.
In this study, carrier matrices used the SiO2, SiO2–CaO, SiO2–PDMS and SiO2–
CaO–PDMS xerogels. The modifications of silica xerogel may improve its
properties: the bioactivity (due to the addition of calcium ions) and flexibility
(due to the use of PDMS). Consequently, these matrices may be useful as the bone-
substitute materials.
The pure silica xerogel exhibited the high surface area and the largest average
pore size. The SiO2–CaO xerogel showed a negligible increase in surface area but a
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Fig. 7 Kinetics of
Metronidazole release from
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decrease in pore volume and pore radius. Modification of material by adding PDMS
decreased both the surface area and the average pore size. Moreover, partial
substitution of SiO2 with CaO and especially with PDMS results in decreasing of
degree of matrix degradation.
The sol–gel method used to synthesize xerogels containing Metronidazole was
also found to be useful for the synthesis of controlled release drug delivery systems.
The xerogel/Metronidazole material showed a similar diphasic release profile of
the drug, whose mechanism was found to be diffusion controlled.
The percent of cumulative release of Metronidazole from silica xerogels was
strongly correlated with physical properties of matrices. From the four types of
xerogels tested, pure silica matrix of greatest hydrophilicity and biggest pore size
was much more effective than modified silica xerogels. Xerogels, SiO2, SiO2–
PDMS and SiO2–PDMS–CaO, showed a final Metronidazole release of *100, 94
and *90%, respectively, while SiO2–CaO xerogel showed a final release of 71% of
encapsulated Metronidazole.
The reports [10, 39, 40], which exhibit biocompatibility and bioactivity sol–gel
ceramics combined with this study, suggest that these xerogel materials could be
promising candidates for formulation in local delivery systems as controlled release
materials for the treatment of bone infections or for repairing periodontal defects in
dentistry.
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